| Peer-Reviewed

Treating Benign Halo Nevus and Focal Vitiligo with Topical Tacrolimus: A Brief Report

Received: 24 September 2014     Accepted: 30 September 2014     Published: 10 October 2014
Views:       Downloads:
Abstract

Three patients had been suffering from benign halo nevus and focal vitiligo. They were treated with topical tacrolimus for 12 months. Remission was achieved in both the diseases. Pigmented moles of the halo nevi were unchanged and no harm was incurred to the patients. There was minimal self-limiting side effect from the tacrolimus.

Published in American Journal of Clinical and Experimental Medicine (Volume 2, Issue 5)
DOI 10.11648/j.ajcem.20140205.13
Page(s) 103-105
Creative Commons

This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited.

Copyright

Copyright © The Author(s), 2014. Published by Science Publishing Group

Keywords

Benign Halo Nevus, Focal Vitiligo, Treatment, Topical Tacrolimus

References
[1] Stierman SC, Tierney EP, Shwayder TA. Halo congenital nevocellular nevi associated with extra lesional vitiligo. A case series with review of the literature. Pediatr Dermatol, 2009; 26: 414-424.
[2] Frank SB and Cohen JH. The halo nevi. Archive Dermatol 1964; 89: 367-73.
[3] Pearl E. Grimes, MD, Teresa Soriano, MD, and Mailene T. Dytoc MD, Ph D. Topical tacrolimus for repigmentation of vitiligo. J Am Acad Dermatol 2002; 47: 789-91.
[4] William L. Epstein, MD; Richard Sagebeil, MD; Lynn Spitler, MD; Joseph Wybran, MD; William B. Reed, MD; M. Scot Blois. Halo nevi and melanoma. JAMA. 1973; 225(4): 373-377.
[5] Copeman, P. W. M., Lewis, M. G., and Elliott, P. G. Immunological Associations of the Halo Naevus with Cutaneous Malignant Melanoma. Brit. J. Dermatol 1973; 88: 127-137.
[6] Lawrence I. Tacrolimus (FK 506) experience in dermatology. Dermatol Ther 1998; 5: 74-84.
Cite This Article
  • APA Style

    Delwar Hossain. (2014). Treating Benign Halo Nevus and Focal Vitiligo with Topical Tacrolimus: A Brief Report. American Journal of Clinical and Experimental Medicine, 2(5), 103-105. https://doi.org/10.11648/j.ajcem.20140205.13

    Copy | Download

    ACS Style

    Delwar Hossain. Treating Benign Halo Nevus and Focal Vitiligo with Topical Tacrolimus: A Brief Report. Am. J. Clin. Exp. Med. 2014, 2(5), 103-105. doi: 10.11648/j.ajcem.20140205.13

    Copy | Download

    AMA Style

    Delwar Hossain. Treating Benign Halo Nevus and Focal Vitiligo with Topical Tacrolimus: A Brief Report. Am J Clin Exp Med. 2014;2(5):103-105. doi: 10.11648/j.ajcem.20140205.13

    Copy | Download

  • @article{10.11648/j.ajcem.20140205.13,
      author = {Delwar Hossain},
      title = {Treating Benign Halo Nevus and Focal Vitiligo with Topical Tacrolimus: A Brief Report},
      journal = {American Journal of Clinical and Experimental Medicine},
      volume = {2},
      number = {5},
      pages = {103-105},
      doi = {10.11648/j.ajcem.20140205.13},
      url = {https://doi.org/10.11648/j.ajcem.20140205.13},
      eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ajcem.20140205.13},
      abstract = {Three patients had been suffering from benign halo nevus and focal vitiligo. They were treated with topical tacrolimus for 12 months. Remission was achieved in both the diseases. Pigmented moles of the halo nevi were unchanged and no harm was incurred to the patients. There was minimal self-limiting side effect from the tacrolimus.},
     year = {2014}
    }
    

    Copy | Download

  • TY  - JOUR
    T1  - Treating Benign Halo Nevus and Focal Vitiligo with Topical Tacrolimus: A Brief Report
    AU  - Delwar Hossain
    Y1  - 2014/10/10
    PY  - 2014
    N1  - https://doi.org/10.11648/j.ajcem.20140205.13
    DO  - 10.11648/j.ajcem.20140205.13
    T2  - American Journal of Clinical and Experimental Medicine
    JF  - American Journal of Clinical and Experimental Medicine
    JO  - American Journal of Clinical and Experimental Medicine
    SP  - 103
    EP  - 105
    PB  - Science Publishing Group
    SN  - 2330-8133
    UR  - https://doi.org/10.11648/j.ajcem.20140205.13
    AB  - Three patients had been suffering from benign halo nevus and focal vitiligo. They were treated with topical tacrolimus for 12 months. Remission was achieved in both the diseases. Pigmented moles of the halo nevi were unchanged and no harm was incurred to the patients. There was minimal self-limiting side effect from the tacrolimus.
    VL  - 2
    IS  - 5
    ER  - 

    Copy | Download

Author Information
  • Department of Dermatology and Venereology, University of Science and Technology ,Chittagong (USTC), Foy’s Lake, Khulsi, Chittagong, Bangladesh

  • Sections